News_剂泰科技（北京）股份有限公司

CN

Home

About us

Platforms

Pipeline

Partners

News

Investors

Careers

Contact us
News
News

METiS Selected as MIT Technology Review's 50 Smartest Companies (TR50)

News
METiS Selected as MIT Technology Review's 50 Smartest Companies (TR50)
2025.09.13

METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing’s Biopharmaceutical Innovation Engine

News
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing’s Biopharmaceutical Innovation Engine
2025.08.01

METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting

News
METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting
2025.07.22

METiS Pharmaceuticals Announces Formation of Scientific Advisory Board Comprising World-Renowned Experts

News
METiS Pharmaceuticals Announces Formation of Scientific Advisory Board Comprising World-Renowned Experts
2025.04.25
METiS Selected as MIT Technology Review's 50 Smartest Companies (TR50)
METiS Selected as MIT Technology Review's 50 Smartest Companies (TR50)
2025.09.13
News
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing’s Biopharmaceutical Innovation Engine
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing’s Biopharmaceutical Innovation Engine
2025.08.01
News
METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting
METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting
2025.07.22
News
Day One Global | METiS Technologies Selected for the “2025 Top 100 Emerging Chinese Companies in Globalization” List
Day One Global | METiS Technologies Selected for the “2025 Top 100 Emerging Chinese Companies in Globalization” List
2025.07.08
News
METiS CEO Dr. Chris Lai Attends IARO International Summit: AI Nanotargeted Delivery Expected to Achieve Personalized Anti-Aging Through Senescent Cell Reprogramming
METiS CEO Dr. Chris Lai Attends IARO International Summit: AI Nanotargeted Delivery Expected to Achieve Personalized Anti-Aging Through Senescent Cell Reprogramming
2025.07.03
News
METiS Pharmaceuticals Announces Formation of Scientific Advisory Board Comprising World-Renowned Experts
METiS Pharmaceuticals Announces Formation of Scientific Advisory Board Comprising World-Renowned Experts
2025.04.25
News
1234567
This website uses cookies.
This website uses cookies to improve your experience when visiting this website. However, if you do not agree, you can also choose to cancel.
For more information, please refer to our Privacy Policy.